Apligraf

Apligraf

Graftskin Wound care A proprietary manufactured human skin equivalent/artificial skin containing living cells used to cover venous ulcers, burn wounds, diabetic and decubitus ulcers. See Artificial skin.
References in periodicals archive ?
The company's FDA-approved bioengineered living cell-based therapies, Apligraf and Dermagraft, have also experienced strong sales growth, with more than 1 million units of Apligraf and Dermagraft shipped for patient applications to date.
M2 EQUITYBITES-November 4, 2015-Swissmedic grants marketing authorisation to Organogenesis' Apligraf
M2 PHARMA-November 4, 2015-Swissmedic grants marketing authorisation to Organogenesis' Apligraf
This award will streamline the purchasing process for Veterans Affairs Medical Centers to gain easier access to Apligraf.
We have already seen commercial success in the tissue engineering sector with products such as Dermagraft and Apligraf.
Organogenesis announced that its Apligraf bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA).
Clinical studies have shown that Apligraf in combination with a standard therapy is more efficient in healing diabetic foot ulcers or venous leg ulcers than standard therapy alone.
Disclosures: This study was supported in part by Organogenesis, makers of Apligraf.
NEW ORLEANS -- Apligraf has been used successfully to line a new vagina in a patient with Mayer-Rokitansky-Kuster-Hauser syndrome.
If the ulcers to not health within 12 weeks, the patients will receive Organogenesis' lead product Apligraf to complete the healing process.
AMEX:ORG) has reported that US commercial sales of lead product Apligraf reached 4084 units for the fourth quarter of 2000, up from 3232 units for the previous quarter.